Skip to main content

and
  1. Article

    Open Access

    Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

    To evaluate the use of high-dose radiotherapy using carbon ions (C12) on non-adenoid cystic malignant salivary gland tumors (MSGT).

    A. D. Jensen, M. Poulakis, V. Vanoni, M. Uhl, N. Chaudhri in Radiation Oncology (2016)